Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778888) titled 'BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial' on Aug. 18.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Bausch & Lomb Incorporated
Condition:
Dry Eye Disease
Intervention:
Drug: BL1107
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2026
Target Sample Size: 20
To know more, visit https://clinicaltrials.gov/study/NCT07778888
Disclaimer: Curated by HT Syndication....